Scholars Central

Research articlePublished 8 Jul 2017

EFFECT OF TOPICAL BRIMONIDINE 0.15% VERSUS TIMOLOL 0.5% TO PREVENT INTRAOCULAR PRESSURE ELEVATION AFTER Nd-YAG LASER CAPSULOTOMY

Authors: Amruth Lal Yellamelli, Vibha Florence Baldev, Nitin Batra, Arun Bhatti

Journal of Evidence-Based Medicine and Healthcare

Volume 4 · Issue 7 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND Posterior capsular opacification (PCO) is the most common long term complication of modern extra capsular cataract surgery techniques including phacoemulsification. The treatment of choice for clinically significant posterior capsule opacification is Neodymium: Yttrium-Aluminium-Garnet (Nd:YAG) laser posterior capsulotomy. Increased IOP is a well-known complication of Nd:YAG laser posterior capsulotomy Effective prophylaxis could prevent the possible optic nerve damage or visual field loss in susceptible patients. MATERIALS AND METHODS This prospective randomized study was conducted for one year in the Department of Ophthalmology Christian Medical College and Hospital, Ludhiana. All patients undergoing laser capsulotomy during this period were randomly distributed into two groups – A or B. Group A received 1 drop of Brimonidine 0.15%, Group B received 1 drop of 0.5% Timolol, one hour prior to presentation. Nd:YAG laser Capsulotomy was done. IOP was measured using an applanation tonometer after 1 hr, 2 hrs, 3 hrs and 4 hrs. after completion of procedure. The data was collected as per protocol and statistically analysed using t-test, Chi square test and Z test. RESULTS There were 30 patients in each group. The baseline IOP was 15.10 ± 2.66 mmHg for group A and 16 ± 2.18 mmHg for group B (p = 0.11) (t test). There was no statistically significant reduction between the two groups in the mean IOP changes at 1, 2 or 3 hrs after Nd:YAG capsulotomy. The mean reduction in IOP after 4 hrs. for group was -1.83 mmHg and for group B was - 1.53 mmHg. The difference was statistically significant (p <0.05). CONCLUSION Brimonidine 0.15% was found to have an efficacy comparable to that of Timolol 0.5% in preventing post Nd:YAG capsulotomy IOP spikes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Evidence-Based Medicine and Healthcare.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Amruth Lal Yellamelli”
  • BylineArticles whose byline prints “Vibha Florence Baldev”
  • BylineArticles whose byline prints “Nitin Batra”
  • BylineArticles whose byline prints “Arun Bhatti”